How to Foster Communication Among all Members of the Cancer Care Team with Pathologists to Deliver Individualized Treatment for Patients with Lung Cancer

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs Roy Herbst and David Rimm consider novel ways that surgeons, interventional radiologists, pulmonologists, medical oncologists, and pathologists interact at Yale Cancer Center to maximize the use of common molecular biomarkers, as well as NGS and TMB, in providing precision medicine to lung cancer patients.

October 16, 2015

Melanoma in Personalized Medicine and Biomarkers

Dr. Sanjiv Agarwala talks about the importance of personalizing melanoma care, focusing on where the industry currently stands and what’s in store for the future of targeted therapies and immunotherapies.

November 10, 2012

PMO Interview with the Innovator Series: Volume 4

Tom Reynolds, Chief Medical Officer of Seattle Genetics, offers a definition of personal medicine in this new video series from Personalized Medicine in Oncology.